The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)-Global Market Insights and Sales Trends 2025
Synopsis
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. Paracetamol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ibuprofen segment is estimated at % CAGR for the next seven-year period.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) covered in this report include Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma and Dr. Reddy's Laboratories, etc.
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, Segment by Type:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. Paracetamol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ibuprofen segment is estimated at % CAGR for the next seven-year period.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) covered in this report include Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma and Dr. Reddy's Laboratories, etc.
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, Segment by Type:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
1.1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Scope
1.1.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Status and Outlook
1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2018-2029)
1.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2018-2023)
1.5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2029)
1.6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2029)
1.6.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2029)
1.6.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2029)
1.6.4 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2029)
1.6.5 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2018-2029)
2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Type
2.1 Introduction
2.1.1 Paracetamol
2.1.2 Ibuprofen
2.1.3 Aspirin
2.1.4 Naproxen
2.1.5 Others
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2018-2023)
2.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Type (2018-2029)
3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2018-2023)
3.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Breakdown by Application (2018-2029)
4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Competition Analysis by Players
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2022)
4.3 Date of Key Players Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
4.4 Global Top Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Headquarters and Area Served
4.5 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
4.6 Competitive Status
4.6.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.1.4 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.2.4 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.3.4 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.3.5 Teva Pharmaceutical Recent Developments
5.4 Teva Pharmaceutical
5.4.1 Teva Pharmaceutical Profile
5.4.2 Teva Pharmaceutical Main Business
5.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.4.4 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.4.5 Teva Pharmaceutical Recent Developments
5.5 Hospira
5.5.1 Hospira Profile
5.5.2 Hospira Main Business
5.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.5.4 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.5.5 Hospira Recent Developments
5.6 Lonza Group
5.6.1 Lonza Group Profile
5.6.2 Lonza Group Main Business
5.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.6.4 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.6.5 Lonza Group Recent Developments
5.7 Mylan
5.7.1 Mylan Profile
5.7.2 Mylan Main Business
5.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.7.4 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.7.5 Mylan Recent Developments
5.8 Aurobindo Pharma
5.8.1 Aurobindo Pharma Profile
5.8.2 Aurobindo Pharma Main Business
5.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.8.4 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.8.5 Aurobindo Pharma Recent Developments
5.9 Dr. Reddy's Laboratories
5.9.1 Dr. Reddy's Laboratories Profile
5.9.2 Dr. Reddy's Laboratories Main Business
5.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.9.4 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.9.5 Dr. Reddy's Laboratories Recent Developments
5.10 Actavis
5.10.1 Actavis Profile
5.10.2 Actavis Main Business
5.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.10.4 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.10.5 Actavis Recent Developments
5.11 Wuxi Apptec
5.11.1 Wuxi Apptec Profile
5.11.2 Wuxi Apptec Main Business
5.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.11.4 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.11.5 Wuxi Apptec Recent Developments
5.12 Zhejiang NHU
5.12.1 Zhejiang NHU Profile
5.12.2 Zhejiang NHU Main Business
5.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products, Services and Solutions
5.12.4 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$ Million) & (2018-2023)
5.12.5 Zhejiang NHU Recent Developments
6 North America
6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
11.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
11.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
11.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
